Korro Bio Inc (KRRO)

Apr 01, 2025

Korro Bio appoints new Chief Scientific Officer By Investing.com - Investing.com South Africa

Apr 01, 2025

Apr 01, 2025

Korro Bio appoints new Chief Scientific Officer - Investing.com

Apr 01, 2025

Apr 01, 2025

Korro Appoints Biotech Industry Veteran, Loïc Vincent, Ph.D., as Chief Scientific Officer - The Manila Times

Apr 01, 2025

Apr 01, 2025

RNA-Editing Pioneer Korro Bio Lands Elite CSO with 20+ Drug Development Success Record - Stock Titan

Apr 01, 2025

Mar 28, 2025

Korro Bio: Promising Early Stage RNA Editing Company (NASDAQ:KRRO) - Seeking Alpha

Mar 28, 2025

Mar 28, 2025

Korro Bio reappoints CFO, names new principal accounting officer By Investing.com - Investing.com Canada

Mar 28, 2025

Mar 27, 2025

Korro Bio CFO Returns from Medical Leave - TipRanks

Mar 27, 2025

Mar 27, 2025

Korro Bio reappoints CFO, names new principal accounting officer - Investing.com

Mar 27, 2025

Mar 27, 2025

Korro Bio Inc Vineet Agarwal Ends Temporary Medical Leave As CFO - MarketScreener

Mar 27, 2025

Mar 24, 2025

Research Analysts Set Expectations for Korro Bio Q1 Earnings - Defense World

Mar 24, 2025

Mar 23, 2025

Q1 Earnings Forecast for Korro Bio Issued By William Blair - Armenian Reporter

Mar 23, 2025

Mar 22, 2025

HC Wainwright Reiterates Buy Rating for Korro Bio (NASDAQ:KRRO) - Defense World

Mar 22, 2025

Mar 22, 2025

Q1 Earnings Estimate for Korro Bio Issued By William Blair - Defense World

Mar 22, 2025

Mar 21, 2025

Royal Bank of Canada Has Lowered Expectations for Korro Bio (NASDAQ:KRRO) Stock Price - Defense World

Mar 21, 2025

Mar 21, 2025

Korro Bio Reports 2024 Financial Results and Progress - TipRanks

Mar 21, 2025

Mar 20, 2025

H.C. Wainwright maintains Buy rating on Korro Bio stock By Investing.com - Investing.com Australia

Mar 20, 2025

Mar 20, 2025

H.C. Wainwright maintains Buy rating on Korro Bio stock - Investing.com

Mar 20, 2025

Mar 20, 2025

Korro Bio, Inc. (NASDAQ:KRRO) Given Consensus Recommendation of “Buy” by Analysts - Defense World

Mar 20, 2025

Mar 19, 2025

Korro Bio’s SWOT analysis: RNA editing firm’s stock poised for growth - Investing.com Australia

Mar 19, 2025

Mar 19, 2025

Korro Bio’s SWOT analysis: RNA editing firm’s stock poised for growth By Investing.com - Investing.com South Africa

Mar 19, 2025

Mar 19, 2025

Is Korro Bio (NASDAQ:KRRO) In A Good Position To Invest In Growth? - Yahoo Finance

Mar 19, 2025

Mar 19, 2025

RBC Cuts Price Target on Korro Bio to $95 From $105, Keeps Outperform, Speculative Risk - Marketscreener.com

Mar 19, 2025

Mar 19, 2025

Korro Bio’s Promising Growth: Buy Rating Backed by Positive KRRO-110 Trial Progress and Market Opportunities - TipRanks

Mar 19, 2025

Mar 18, 2025

Korro Bio, Inc. SEC 10-K Report - TradingView

Mar 18, 2025

Mar 18, 2025

Korro Reports Full Year 2024 Financial Results and Provides Business Updates - The Manila Times

Mar 18, 2025

Mar 18, 2025

Korro Bio Reports Clean Safety Data in AATD Drug Trial, Secures $163M Runway - StockTitan

Mar 18, 2025

Mar 18, 2025

Korro Bio (KRRO) Projected to Post Earnings on Tuesday - Defense World

Mar 18, 2025

Mar 15, 2025

FDA grants orphan drug status to Korro’s AATD treatment By Investing.com - Investing.com Australia

Mar 15, 2025

Mar 14, 2025

Korro Bio gets FDA Orphan Drug tag (KRRO:NASDAQ) - Seeking Alpha

Mar 14, 2025

Mar 14, 2025

Korro Bio's Potential Antitrypsin Deficiency Treatment Receives US FDA Orphan Drug Designation - Marketscreener.com

Mar 14, 2025

Mar 14, 2025

FDA grants orphan drug status to Korro’s AATD treatment - Investing.com

Mar 14, 2025

Mar 14, 2025

KRRO-110 Receives Orphan Drug Designation from U.S. FDA for Alpha-1 Antitrypsin Deficiency - The Manila Times

Mar 14, 2025

Mar 14, 2025

Breakthrough for Rare Disease: FDA Awards Special Status to Korro Bio's Novel RNA Treatment - StockTitan

Mar 14, 2025

Mar 10, 2025

Rhumbline Advisers Purchases 691 Shares of Korro Bio, Inc. (NASDAQ:KRRO) - Defense World

Mar 10, 2025

Feb 26, 2025

Korro to Present at the TD Cowen 45th Annual Health Care Conference - The Manila Times

Feb 26, 2025

Feb 26, 2025

What Will Korro Bio Reveal at the TD Cowen Healthcare Conference Next Week? - StockTitan

Feb 26, 2025

Feb 23, 2025

Korro Bio, Inc. (NASDAQ:KRRO) Receives Average Rating of “Buy” from Analysts - Defense World

Feb 23, 2025

Feb 20, 2025

KRRO stock touches 52-week low at $28.71 amid market challenges - Investing.com Nigeria

Feb 20, 2025

Feb 13, 2025

Korro Bio CFO takes medical leave, interim officers appointed - MSN

Feb 13, 2025

Feb 11, 2025

Korro Bio CFO takes medical leave, interim officers appointed By Investing.com - Investing.com Nigeria

Feb 11, 2025

Feb 11, 2025

Korro Bio Appoints Interim CFO Amid Medical Leave - TipRanks

Feb 11, 2025

Feb 11, 2025

Korro Bio, Inc. Appoints Oliver Dolan as Interim Principal Accounting Officer -February 11, 2025 at 04:05 pm EST - Marketscreener.com

Feb 11, 2025

Feb 11, 2025

KRRO stock touches 52-week low at $29.8 amid yearly slump - Investing.com

Feb 11, 2025

Feb 05, 2025

AllianceBernstein L.P.'s Strategic Acquisition of Korro Bio Inc Shares - GuruFocus.com

Feb 05, 2025

Feb 01, 2025

Korro Bio, Inc. (NASDAQ:KRRO) Receives Average Recommendation of "Buy" from Brokerages - MarketBeat

Feb 01, 2025

Jan 30, 2025

JPMorgan Chase & Co. Boosts Stock Holdings in Korro Bio, Inc. (NASDAQ:KRRO) - MarketBeat

Jan 30, 2025

Jan 30, 2025

Korro Bio, Inc. (NASDAQ:KRRO) Shares Bought by JPMorgan Chase & Co. - Defense World

Jan 30, 2025

Jan 29, 2025

Korro Bio, Inc. (NASDAQ:KRRO) Receives Consensus Rating of “Buy” from Analysts - Defense World

Jan 29, 2025